|
National
Accreditation Board for Testing and Calibration
Laboratories (NABL) has accredited the Clinical
Laboratory of Clinical Pharmacology Department
of Aurobindo Pharma Limited, in the areas of
Clinical Biochemistry, Clinical Pathology,
Serology and Haematology as per ISO/IEC
17025:1999. |
|
Set up as an
autonomous body under the aegis of Department of
Science & Technology, Government of India, NABL
is the sole accreditation body for Testing and
Calibration laboratories. The accreditation is a
formal recognition of the technical competence
of a testing or calibration laboratory for a
specific task following ISO/IEC 17025 Standard.
This is based on third party assessment. |
|
NABL accreditation
has assumed significance for equivalence of
measurements for manufacturing industries, which
source their components from different
countries. Laboratory Accreditation provides
formal recognition of competent laboratories,
thus providing a ready means for customers to
find reliable testing and calibration services
in order to meet their demands. |
|
Accreditation to a
laboratory is given on the basis of its
capability to perform test(s) / calibration(s)
and provide accurate and reliable results.
Laboratory Accreditation enhances customer
confidence in accepting testing / calibration
reports issued by accredited laboratories.
|
|
Aurobindo Pharma in
its pursuit of excellence in delivering quality
pharma products to customers rededicates its
commitment to the cause of science and medicine.
The accreditation strengthens this resolve. |
About Aurobindo
Pharma Ltd
Aurobindo Pharma Limited based at Hyderabad,
India manufactures Generic pharmaceuticals and
Active Pharmaceutical Ingredients. The company’s
robust product portfolio is spread over 6 major
product areas encompassing (Antibiotics,
Anti-Retro Virals, CVS, CNS,
Gastroenterologicals, and Anti-Allergics) with
around 65 APIs in the Non-Antibiotics and over
55 APIs in the Antibiotic segment. The Company
reaches out with its products to over 100
countries. |
PRESS
ROOM 
